US EditionTELA Bio Posts Double-Digit Revenue Growth, Expands Product Reach in Q2
Summary by MyChesCo
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
TELA Bio Posts Double-Digit Revenue Growth, Expands Product Reach in Q2
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) reported a strong second quarter for 2025, delivering $20.2 million in revenue, up 26% from the same period last year and 9% from the previous quarter. The growth was driven by higher demand for its OviTex® and OviTex PRS Reinforced Tissue Matrix products, which saw revenue gains of approximately 12% and 53% year-over-year, respectively. The company also marked a significant milestone with the European…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
